238 related articles for article (PubMed ID: 27134688)
1. Vitamin C enhances epigenetic modifications induced by 5-azacytidine and cell cycle arrest in the hepatocellular carcinoma cell lines HLE and Huh7.
Sajadian SO; Tripura C; Samani FS; Ruoss M; Dooley S; Baharvand H; Nussler AK
Clin Epigenetics; 2016; 8():46. PubMed ID: 27134688
[TBL] [Abstract][Full Text] [Related]
2. Induction of active demethylation and 5hmC formation by 5-azacytidine is TET2 dependent and suggests new treatment strategies against hepatocellular carcinoma.
Sajadian SO; Ehnert S; Vakilian H; Koutsouraki E; Damm G; Seehofer D; Thasler W; Dooley S; Baharvand H; Sipos B; Nussler AK
Clin Epigenetics; 2015; 7(1):98. PubMed ID: 26366235
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic Modifications of the Liver Tumor Cell Line HepG2 Increase Their Drug Metabolic Capacity.
Ruoß M; Damm G; Vosough M; Ehret L; Grom-Baumgarten C; Petkov M; Naddalin S; Ladurner R; Seehofer D; Nussler A; Sajadian S
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30654452
[TBL] [Abstract][Full Text] [Related]
4. Treatment with MAPKAP2 (MK2) inhibitor and DNA methylation inhibitor, 5-aza dC, synergistically triggers apoptosis in hepatocellular carcinoma (HCC) via tristetraprolin (TTP).
Tran DDH; Koch A; Allister A; Saran S; Ewald F; Koch M; Nashan B; Tamura T
Cell Signal; 2016 Dec; 28(12):1872-1880. PubMed ID: 27619201
[TBL] [Abstract][Full Text] [Related]
5. Genetic and epigenetic inactivation of T-cadherin in human hepatocellular carcinoma cells.
Chan DW; Lee JM; Chan PC; Ng IO
Int J Cancer; 2008 Sep; 123(5):1043-52. PubMed ID: 18553387
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte growth factor activator inhibitor 2/placental bikunin (HAI-2/PB) gene is frequently hypermethylated in human hepatocellular carcinoma.
Fukai K; Yokosuka O; Chiba T; Hirasawa Y; Tada M; Imazeki F; Kataoka H; Saisho H
Cancer Res; 2003 Dec; 63(24):8674-9. PubMed ID: 14695180
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells.
Zhang C; Li H; Zhou G; Zhang Q; Zhang T; Li J; Zhang J; Hou J; Liew CT; Yin D
J Pathol; 2007 Jun; 212(2):134-42. PubMed ID: 17471463
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition.
Quan H; Zhou F; Nie D; Chen Q; Cai X; Shan X; Zhou Z; Chen K; Huang A; Li S; Tang N
Oncogene; 2014 May; 33(22):2826-35. PubMed ID: 23770846
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic combination therapy as a tumor-selective treatment approach for hepatocellular carcinoma.
Venturelli S; Armeanu S; Pathil A; Hsieh CJ; Weiss TS; Vonthein R; Wehrmann M; Gregor M; Lauer UM; Bitzer M
Cancer; 2007 May; 109(10):2132-41. PubMed ID: 17407132
[TBL] [Abstract][Full Text] [Related]
10. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic inactivation of the tumor suppressor gene RIZ1 in hepatocellular carcinoma involves both DNA methylation and histone modifications.
Zhang C; Li H; Wang Y; Liu W; Zhang Q; Zhang T; Zhang X; Han B; Zhou G
J Hepatol; 2010 Nov; 53(5):889-95. PubMed ID: 20675009
[TBL] [Abstract][Full Text] [Related]
12. 5-Aza-2<-deoxycytidine induces hepatoma cell apoptosis via enhancing methionine adenosyltransferase 1A expression and inducing S-adenosylmethionine production.
Liu WJ; Ren JG; Li T; Yu GZ; Zhang J; Li CS; Liu ZS; Liu QY
Asian Pac J Cancer Prev; 2013; 14(11):6433-8. PubMed ID: 24377546
[TBL] [Abstract][Full Text] [Related]
13. Tissue factor pathway inhibitor-2 as a frequently silenced tumor suppressor gene in hepatocellular carcinoma.
Wong CM; Ng YL; Lee JM; Wong CC; Cheung OF; Chan CY; Tung EK; Ching YP; Ng IO
Hepatology; 2007 May; 45(5):1129-38. PubMed ID: 17464989
[TBL] [Abstract][Full Text] [Related]
14. Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma.
Grossi I; Arici B; Portolani N; De Petro G; Salvi A
Oncotarget; 2017 Jan; 8(4):6955-6969. PubMed ID: 28036298
[TBL] [Abstract][Full Text] [Related]
15. Differentiation Therapy by Epigenetic Reconditioning Exerts Antitumor Effects on Liver Cancer Cells.
Gailhouste L; Liew LC; Yasukawa K; Hatada I; Tanaka Y; Nakagama H; Ochiya T
Mol Ther; 2018 Jul; 26(7):1840-1854. PubMed ID: 29759938
[TBL] [Abstract][Full Text] [Related]
16. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU.
Li X; Yu J; Brock MV; Tao Q; Herman JG; Liang P; Guo M
Oncotarget; 2015 May; 6(13):11547-60. PubMed ID: 25909168
[TBL] [Abstract][Full Text] [Related]
18. Analysis of possible mechanisms accounting for raf-1 kinase inhibitor protein downregulation in hepatocellular carcinoma.
Poma P; Labbozzetta M; Vivona N; Porcasi R; D'Alessandro N; Notarbartolo M
OMICS; 2012 Nov; 16(11):579-88. PubMed ID: 23095110
[TBL] [Abstract][Full Text] [Related]
19. Serum response factor induces epithelial to mesenchymal transition with resistance to sorafenib in hepatocellular carcinoma.
Bae JS; Noh SJ; Kim KM; Jang KY; Chung MJ; Kim DG; Moon WS
Int J Oncol; 2014 Jan; 44(1):129-36. PubMed ID: 24173109
[TBL] [Abstract][Full Text] [Related]
20. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma.
Iwata N; Yamamoto H; Sasaki S; Itoh F; Suzuki H; Kikuchi T; Kaneto H; Iku S; Ozeki I; Karino Y; Satoh T; Toyota J; Satoh M; Endo T; Imai K
Oncogene; 2000 Nov; 19(46):5298-302. PubMed ID: 11077447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
